Anti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve Markers (Q26765770)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26977116%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

3 references

29 July 2020

19 November 2020

31 January 2021

Anti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve Markers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26977116%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

0 references

1 reference

9 October 2019

1 reference

10 October 2019

1 reference

17 November 2019

1 reference

18 November 2019

1 reference

29 July 2020

1 reference

19 November 2020

Anti-Mullerian hormone

1 reference

31 January 2021

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26977116%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Zehra Jamil

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26977116%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Khalid Ahmed

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26977116%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Rabia Malik

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26977116%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

language of work or name

English

0 references

publication date

10 February 2016

9 references

19 June 2019

9 October 2019

10 October 2019

17 November 2019

18 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26977116%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

29 July 2020

19 November 2020

31 January 2021

9 references

19 June 2019

9 October 2019

10 October 2019

17 November 2019

18 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26977116%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

29 July 2020

19 November 2020

31 January 2021

2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26977116%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

5246217

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26977116%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

10 March 2020

copyright license

8 references

19 June 2019

9 October 2019

10 October 2019

17 November 2019

18 November 2019

29 July 2020

19 November 2020

A validated model of serum anti-müllerian hormone from conception to menopause

31 January 2021

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Inhibin at 90: from discovery to clinical application, a historical review

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

The physiology and clinical utility of anti-Mullerian hormone in women

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Anti-müllerian hormone as a sensitive marker of ovarian function in young cancer survivors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Anti-müllerian hormone and its clinical use in pediatrics with special emphasis on disorders of sex development.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Updated assays for inhibin B and AMH provide evidence for regular episodic secretion of inhibin B but not AMH in the follicular phase of the normal menstrual cycle

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Potential mechanisms for racial and ethnic differences in antimüllerian hormone and ovarian reserve

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

The circadian variation in Anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

The significance of serum anti-Müllerian hormone (AMH) levels in patients over age 40 in first IVF treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Can anti-Müllerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Biomarkers of ovarian response: current and future applications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Testicular anti-Müllerian hormone: clinical applications in DSD.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Multiple approaches for individualized fertility protective therapy in cancer patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

The clinical significance of anti-Müllerian hormone evaluation in gynecological endocrinology.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Ovarian metabolism of xenobiotics

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

The role of anti-Müllerian hormone assessment in assisted reproductive technology outcome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Ovarian function and obesity--interrelationship, impact on women's reproductive lifespan and treatment options

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

The antral follicle count: practical recommendations for better standardization

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Medical therapy for clinically non-functioning pituitary adenomas

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Reproductive endocrinology and clinical aspects of obesity in women

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

The impact of luteinizing hormone in assisted reproduction: a review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Clinical practice in Turner syndrome.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Regulation and function of inhibins in the normal menstrual cycle.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

MIS/AMH in the assessment of cryptorchidism and intersex conditions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Hormonal changes in the menopause transition

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Ovarian reserve testing and the use of prognostic models in patients with subfertility

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications

28 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

28 September 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Follicular dynamics in the polycystic ovary syndrome

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Strategies for ascertaining ovarian reserve among women suspected of subfertility

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Endogenous expression of Müllerian inhibiting substance in early postnatal rat sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Biochemistry of aromatase: significance to female reproductive physiology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts

28 September 2017

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F5246217

Greater inhibition of the pituitary--ovarian axis in oral contraceptive regimens with a shortened hormone-free interval.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F5246217

Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F5246217

Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F5246217

Serum anti-Mullerian hormone throughout the human menstrual cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F5246217

Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F5246217

Serum concentrations of Anti-Müllerian Hormone (AMH) in 95 patients with Klinefelter syndrome with or without cryptorchidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F5246217

Anti-mullerian hormone as a marker of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F5246217

Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F5246217

Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F5246217

Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764725

Anti-Mullerian hormone: clairvoyance or crystal clear?

28 November 2018

1 reference

12 December 2020

Is there any correlation between amh and obesity in premenopausal women?

1 reference

12 December 2020

Antimüllerian hormone as a serum marker of granulosa cell tumorsof the ovary: comparative study with serum alpha-inhibin and estradiol

1 reference

12 December 2020

Hormonal dynamics during luteal-follicular transition

1 reference

12 December 2020

Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection

1 reference

12 December 2020

Stage-specific expression of androgen receptor, follicle-stimulating hormone receptor, and anti-Müllerian hormone type II receptor in single, isolated, human preantral follicles: relevance to polycystic ovaries

1 reference

12 December 2020

Low day 3 luteinizing hormone values are predictive of reduced response to ovarian stimulation

1 reference

12 December 2020

Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?

1 reference

12 December 2020

Polycystic ovary syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1155/2016/5246217

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26977116%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26977116%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26977116%20AND%20SRC:MED&resulttype=core&format=json